Inflammatory mediators in perinatal asphyxia and infection

Area of Science:

• Neonatal immunology
• Perinatal medicine
• Biomarker research

Background:

• Neonatal asphyxia and perinatal infections are significant causes of infant morbidity.
• Inflammatory markers are implicated in the pathophysiology of these conditions.
• Identifying reliable biomarkers is crucial for assessing severity and predicting outcomes.

Purpose of the Study:

• To quantify serum levels of key inflammatory cytokines (IL-6, IL-1beta, TNF-alpha) and adhesion molecules (sICAM-1) in neonates with perinatal asphyxia.
• To compare these inflammatory profiles with those in neonates suffering from perinatal infections.
• To evaluate the correlation between these markers and the severity of perinatal insults, including the risk of brain damage.

Main Methods:

• A cohort of 88 neonates was studied, categorized into asphyxiated (n=36), infected (n=18), and control (n=34) groups.
• Peripheral blood samples were collected on postnatal days 1, 3, and 5.
• Serum levels of IL-6, IL-1beta, TNF-alpha, sICAM-1, and CRP were measured.

Main Results:

• Serum IL-6, IL-1beta, and sICAM-1 levels were significantly elevated in both asphyxiated and infected neonates compared to controls.
• TNF-alpha levels did not differ significantly across the three groups.
• C-reactive protein (CRP) was highest in infected neonates.
• Severe cases of asphyxia and infection showed higher IL-6, IL-1beta, and sICAM-1 levels than mild cases.
• Receiver operating characteristic (ROC) curves were used to establish cut-off points for predicting brain damage risk.

Conclusions:

• Perinatal asphyxia and infection induce similar elevations in serum IL-6, IL-1beta, and sICAM-1.
• The magnitude of these inflammatory marker increases correlates with the severity of perinatal insults.
• These biomarkers may assist in identifying neonates at high risk for brain damage, enabling timely intervention.